Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
-37.86%Return on Equity
VS
Market
Sector
Industry
History
$ 35.65Close
$ 14.86 - $ 39.55 52-Week Range
Ticker Information
Ticker
DNTHCompany Name
DIANTHUS THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDIANTHUS THERAPEUTICS INC - Return on Equity Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
DNTH - ROE Historical data
| Date | Shareholders Equity | Net Income Common Stock | Return on Equity |
|---|---|---|---|
| 6/30/2025 | $ 303.08M | $ -114.75M | -37.86% |
| 3/31/2025 | $ 328.61M | $ -100.73M | -30.65% |
| 12/31/2024 | $ 352.48M | $ -84.97M | -24.11% |
| 9/30/2024 | $ 337.9M | $ -67.09M | -19.86% |
| 6/30/2024 | $ 358.22M | $ -56.68M | -15.82% |
| 3/31/2024 | $ 372.69M | $ -42.36M | -11.37% |
| 12/31/2023 | $ 168.87M | $ -43.55M | -25.79% |
| 9/30/2023 | $ 178.38M | $ -67.39M | -37.78% |
| 6/30/2023 | $ 74.6M | $ -68.69M | -92.08% |
| 3/31/2023 | $ 77.46M | $ -82.68M | -106.74% |
Key Performance Insights, Last 5 Years
- DIANTHUS THERAPEUTICS INC's latest trailing twelve months (TTM) ROE stands at -50.46%.
- Over the past 5 years, DIANTHUS THERAPEUTICS INC's average ROE has been -45.7%.
- The median ROE for DIANTHUS THERAPEUTICS INC during this period was -39.53%
- DIANTHUS THERAPEUTICS INC reached its highest ROE over the past 5 years at -11.37%.
- The lowest ROE recorded by DIANTHUS THERAPEUTICS INC in the same timeframe -106.74%
DIANTHUS THERAPEUTICS INC's ROE vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
ROE Benchmarks
Similar metrics to ROE:
- Net Income Common Stock - [Income Statement] The company's Net Income (loss) [NetInc] less the sum paid on dividends of preferred shares [PrefDivIS].
- Return on Assets - [Calculation] Return on Assets (ROA) measures net income [NetIncCmn] as percentage of total [Assets]. A high ROA shows an effective allocation of capital by the company.
- Shareholders Equity - [Balance Sheet] A principal component of the balance sheet; in addition to [Liabilities] and [Assets]; that represents the total of all stockholders' equity (deficit) after all liabilities have been deducted.
- Net Margin - [Calculation] A company’s Net Income [NetIncCmn] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated.
- Return on Invested Capital - [Calculation] Return on Invested Capital (ROIC) measures how well a company allocates its invested capital to profitable projects and/or investments. It is calculated as net income [NetIncCmn] divided by invested capital [InvCapital].
Definition of Return on Equity
[Calculation] Return on Equity (ROE) measures net income [NetIncCmn] as percentage of [Equity]. A high ROE shows an effective use of investor capital, but it doesn't consider any risks related to financial leverage [Debt].Net Inc. Cmn. / Equity
(=) ROE ROE for DIANTHUS THERAPEUTICS INC is calculated as follows: Net Inc. Cmn. [ $ -80M ] / Equity [ $ 158.57M ]
(=) ROE [ -50.46% ] DNTH - Return on Equity, Last 5 years
-106.74%
Minimum
Mar 31, 2023
-11.37%
Maximum
Mar 31, 2024
-45.7%
Average
-39.53%
Median
ROE Benchmark AnalysisMarket
The chart above depicts the distribution of ROE for companies in the Total Stock Market. The average ROE of the companies is 1.51% with a standard deviation of 22.67%.
The following table provides additional summary stats:
ROE in the Market:
| filtered constituents | 3.14K |
|---|---|
| min | -66.79% |
| max | 73.25% |
| average | 1.51% |
| median | 6.45% |
| std | 22.67% |